La chaîne d'options affiche les données clés des options sur actions de Rua Gold à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Rua Gold..

Rua Gold (OTC:NZAUF) Stock, Chaîne d'Options

Rua Gold Inc is a resource exploration company focused on the acquisition, evaluation and exploration of mineral resource properties. Its has only material mineral property is the Reefton Project.

Rua Gold Inc

The CNN Money Fear and Greed index some decline in market sentiment, while the index remained in the &#8220;Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the Nasdaq Composite jumping more than 1% during the session. Major indices also recorded gains last week, with the S&amp;P 500 adding 4.6% and the Nasdaq jumping 6.7%. The Dow also notched a weekly gain of 2.5%.
Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) shares gained 1.5% after the company reported better-than-expected results for the first quarter. Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares climbed 9.8%, while NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) added 4.3% on Friday.
Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) reported a wider-than-expected loss for the first quarter on Friday.
President Donald Trump claimed to have held a phone call with President Xi Jinping, yet Chinese officials denied that any talks had taken place.
On the economic data front, the University of Michigan consumer sentiment was revised higher to a reading of 52.2 in April versus a preliminary reading of 50.8, and compared to March&#8217;s reading of 57.
Most sectors on the S&amp;P 500 closed on a negative note, with materials, financials and utilities stocks recording biggest losses on Friday. However, consumer discretionary and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 20 points to 40,113.50 on Friday. The S&amp;P 500 jumped 0.74% to 5,525.21, while the Nasdaq Composite surged 1.26% at 17,382.94 during Friday's session.
Investors are awaiting earnings results from Domino&#8217;s Pizza, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>), NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) and Roper Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) today.
At a current reading of 35.3, the index remained in the &#8220;Fear&#8221; zone on Friday, versus a prior reading of 36.9.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/45007118/top-2-health-care-stocks-that-may-crash-this-month">Top 2 Health Care Stocks That May Crash This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GOOG

GOOGL

NVDA

NXPI

TSLA

Nasdaq Jumps Over 200 Points, Investor Fear Increases Slightly, But Fear & Greed Index Remains In 'Fear' Zone

Wells Fargo initiates coverage on Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) with a Equal-Weight rating and announces Price Target of $62.

Price Target

Initiation

Analyst Ratings

Wells Fargo Initiates Coverage On Zillow Gr with Equal-Weight Rating, Announces Price Target of $62

PRTG: 81% &#x7C; <a href="https://www.benzinga.com//node/45034198">Portage Biotech Reports Confirmatory Preclinical Efficacy Data For PORT-7 (TT-4). The New Data In A Murine Mesothelioma Model Demonstrated Single-Agent Activity For PORT-7 That Was Superior To Treatment With Single-Agent Anti-PD1 Antibody</a>
&nbsp;
AMPY: 34% &#x7C; <a href="https://www.benzinga.com//node/45022800">Amplify Energy shares are trading higher after the company announced its termination of the previously announced merger agreement with Juniper Capital</a>
&nbsp;
RVMD: 7% &#x7C; <a href="https://www.benzinga.com//node/45035501">Revolution Medicines shares are trading higher after the company announced new clinical data for zoldonrasib as monotherapy in patients with KRAS G12D mutant non-small cell lung cancer.</a>

Movers

AMPY

PRTG

RVMD

Market-Moving News for April 28th

U.S. stocks settled higher on Friday, with the Nasdaq Composite jumping more than 1% during the session. Major indices also recorded gains last week, with the S&amp;P 500 adding 4.6% and the Nasdaq jumping 6.7%. The Dow also notched a weekly gain of 2.5%.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Richard Davis
<ul>
<li>Analyst Firm: Canaccord Genuity</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained a Buy rating on ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) and increased the price target from $900 to $1,075 on April 24. This analyst sees around 14% upside in the stock.</li>
<li>Recent News: On April 23, ServiceNow reported better-than-expected first-quarter financial results.</li>
</ul>
Analyst: Jay McCanless
<ul>
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Neutral rating on Century Communities, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCS#NYSE">CCS</a>) and cut the price target from $93 to $88 on April 24. This analyst sees around 61% surge in the stock.</li>
<li>Recent News: On April 23, Century Communities reported first-quarter financial results and missed its adjusted EPS and revenue estimates.</li>
</ul>
Analyst: Doug Anmuth 
<ul>
<li>Analyst Firm: JP Morgan</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Overweight rating on Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) and raised the price target from $180 to $195 on April 25. This analyst sees around 19% upside in the stock.</li>
<li>Recent News: On April 24, Alphabet reported better-than-expected first-quarter financial results and announced a 5% increase to the dividend with the quarterly payout going to 21 cents per share.</li>
</ul>
Analyst: Matthew McClintock
<ul>
<li>Analyst Firm: Raymond James</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Outperform rating on Tractor Supply Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) and cut the price target from $61 to $57 on April 25. This analyst sees around 14% upside in the stock.</li>
<li>Recent News: On April 24, The company reported quarterly earnings per share of 34 cents, missing the analyst consensus estimate of 37 cents. Quarterly revenues of $3.47 billion (up 2.1% year over year) missed the street view of $3.54 billion.</li>
</ul>
Analyst: Zachary Fadem
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 84%</li>
<li>Latest Rating: Maintained an Overweight rating on Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) and cut the price target from $60 to $55 on April 24. This analyst sees around 6% upside in the stock.</li>
<li>Recent News: On April 23, Chipotle Mexican Grill reported worse-than-expected first-quarter sales results.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45007044/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend-yields-5">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

TSCO

5 Stocks In The Spotlight Last Week:  Wall Street's Most Accurate Analysts Weigh In

Ascendiant Capital analyst Edward Woo maintains Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) with a Buy and raises the price target from $8.5 to $14.

QUBT

Ascendiant Capital Maintains Buy on Quantum Computing, Raises Price Target to $14

Wells Fargo initiates coverage on Compass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) with a Equal-Weight rating and announces Price Target of $8.

COMP

Wells Fargo Initiates Coverage On Compass with Equal-Weight Rating, Announces Price Target of $8

Airbus SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSF#OTC">EADSF</a>) has agreed to take over assets owned by Spirit Aerosystems Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPR#NYSE">SPR</a>) in a boost to the manufacturer's acquisition by Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>).
What Happened: Airbus will acquire several of Spirit's assets across the globe as part of the deal, including a facility in Kinston, North Carolina, as well as another facility in France. Both facilities manufacture crucial fuselage sections for Airbus's A350 aircraft, Spirit announced in an official statement on Monday.&nbsp;
Others include a facility in Casablanca, Morocco, where the company manufactures A321 and A220 components, as well as parts of facilities in Belfast, Scotland, and Wichita.
The deal stipulates that if no other suitable buyers are found, Airbus will also acquire assets in Subang, Malaysia, related to Airbus programs.
"For many years, Spirit&#8217;s collaboration with Airbus allowed us to deliver aerostructures for some of their most important aircraft programs," said Irene Esteves, Executive VP and CFO at Spirit. She added that this deal will be a boost for the company&#8217;s acquisition by Boeing. 
Airbus will provide Spirit with a $200 million non-interest-bearing credit line, while Spirit will hand over $439 million to Airbus for the assets.
Why It Matters: The sale of assets clears the way for the Spirit's acquisition by Boeing, which <a href="https://www.benzinga.com/24/07/39567358/boeing-to-acquire-spirit-aerosystems-for-4-7b-after-months-of-negotiations">was announced last year</a>, with Boeing paying $4.7 billion after months of negotiations. It's worth noting that Spirit spun off from Boeing in 2005.
The deal with Airbus can also be a boost for Boeing, which is reeling from the effects of the ongoing<a href="https://www.benzinga.com/25/04/44888512/boeing-jet-returns-to-us-amid-escalating-tariff-tensions-with-china"> U.S.-China trade war</a> after the CCP announced a halt on all imports of aircraft made by Boeing into the country.
Boeing also recently secured a deal for <a href="https://www.benzinga.com/tech/25/04/44896693/boeing-secures-new-stocks-of-crucial-nuts-and-bolts-used-in-737-max-production-amid-chinas-import-ban-report">crucial fastening components</a> like nuts and bolts for its best-selling 737 Max model, production of which could've been affected had the manufacturer not replenished its stocks.&nbsp;
Price Action: BA is currently trading for $177.95, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44811150/faulty-bathroom-latches-could-cost-boeing-34-million-following-faa-directive">Faulty Bathroom Latches Could Cost Boeing $3.4 Million Following FAA Directive</a></li>
</ul>
Image Via Shutterstock

Tech

General

EADSF

Airbus Finalizes Deal With Spirit To Take Over Assets, Paving Way For Boeing Acquisition

UBS analyst William Appicelli upgrades Evergy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVRG#NASDAQ">EVRG</a>) from Neutral to Buy and raises the price target from $68 to $78.

Upgrades

EVRG

UBS Upgrades Evergy to Buy, Raises Price Target to $78

Ascendiant Capital analyst Edward Woo maintains Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) with a Buy and lowers the price target from $32 to $30.

KSCP

Ascendiant Capital Maintains Buy on Knightscope, Lowers Price Target to $30

Citigroup analyst Paul Lejuez upgrades On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) from Neutral to Buy and lowers the price target from $65 to $60.

ONON

Citigroup Upgrades On Holding to Buy, Lowers Price Target to $60

WIIM

Revolution Medicines shares are trading higher after the company announced new clinical data for zoldonrasib as monotherapy in patients with KRAS G12D mutant non-small cell lung cancer.

RVTY

Revvity shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance with its midpoint above estimates.

Barclays analyst Paul Kearney initiates coverage on Columbia Sportswear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLM#NASDAQ">COLM</a>) with a Equal-Weight rating and announces Price Target of $64.

COLM

Barclays Initiates Coverage On Columbia Sportswear with Equal-Weight Rating, Announces Price Target of $64

Rithm Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPT#NYSE">RPT</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. The company reported quarterly sales of $2.49 million which missed the analyst consensus estimate of $4.83 million by 48.44 percent.

Earnings Beats

Earnings Misses

Rithm Property Trust Q1 Adj. EPS $0.02 Beats $0.01 Estimate, Sales $2.49M Miss $4.83M Estimate

Ascendiant Capital analyst Edward Woo maintains Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) with a Buy and lowers the price target from $30 to $26.

BNZI

Ascendiant Capital Maintains Buy on Banzai International, Lowers Price Target to $26

Barclays analyst Paul Kearney initiates coverage on Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a Underweight rating and announces Price Target of $4.

Barclays Initiates Coverage On Kohl's with Underweight Rating, Announces Price Target of $4

Barclays analyst Paul Kearney initiates coverage on Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) with a Underweight rating and announces Price Target of $25.

Barclays Initiates Coverage On Carter's with Underweight Rating, Announces Price Target of $25

NANO Nuclear Energy Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on Thursday, April 24, 2025, a Las Vegas judge granted in full two motions to dismiss brought by NANO Nuclear Energy Inc. and its officers and directors in a putative shareholder derivative action entitled Latza v. Walker, et al., Case No. A-24-900423-B, Clark County, Nevada District Court.
"We are extremely pleased that this case has been so promptly adjudicated and dismissed in its entirety," said Jay Yu, Founder and Chairman of NANO Nuclear. "This ruling will allow us to devote more of our time and attention to NANO Nuclear's primary mission of becoming the leading commercially focused advanced nuclear energy technology company in America. We thank our legal team at Ellenoff Grossman &amp; Schole for their insight and hard work in achieving this result."

Legal

Judge Tosses Case Against NANO Nuclear Leaders, Company Refocuses on Advanced Nuclear Tech Growth

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>) with a Buy and raises the price target from $9 to $11.

RNXT

Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $11

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</h3>
<ul>
<li>On April 21, UnitedHealth reported worse-than-expected first-quarter results and cut its FY25 adjusted EPS guidance below estimates. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13 to 16%," said Andrew Witty, CEO of UnitedHealth. The company's stock fell around 19% over the past month and has a 52-week low of $412.02.</li>
<li>RSI Value: 27.1</li>
<li>UNH Price Action: Shares of UnitedHealth fell 1.3% to close at $418.64 on Friday.</li>
<li>Edge Stock Ratings: 26.37 Momentum score with Value at 69.10. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/UNH"><img loading="lazy" decoding="async" width="481" height="192" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28070358/image-186.png" alt="" class="wp-image-890598" style="width:331px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28070358/image-186.png 481w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28070358/image-186-300x120.png 300w" sizes="(max-width: 481px) 100vw, 481px" /></a></figure>
<h3 class="wp-block-heading">Bristol-Myers Squibb Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)&nbsp;&nbsp;</h3>
<ul>
<li>On April 24, Bristol Myers Squibb reported first-quarter 2025 revenues of $11.20 billion, beating the consensus of $10.70 billion. &#8220;Our strong execution in the first quarter drove continued momentum across our Growth Portfolio and meaningful progress in the pipeline,&#8221; said Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb. The company's stock fell around 20% over the past month and<a href="https://www.benzinga.com/quote/BMY"> has a 52-week low</a> of $39.35.</li>
<li>RSI Value: 25</li>
<li>BMY Price Action: Shares of Bristol-Myers Squibb dipped 1.6% to close at $47.90 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0428">BMY stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0428"><img loading="lazy" decoding="async" width="916" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071255/image-187.png" alt="" class="wp-image-890615" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071255/image-187.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071255/image-187-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071255/image-187-768x710.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">X4 Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>)</h3>
<ul>
<li>On April 24, X4 Pharmaceuticals company announced a 1-for-30 reverse stock split. The company has a 52-week <a href="https://www.benzinga.com/quote/XFOR">low of $0.17.</a></li>
<li>RSI Value: 14.7</li>
<li>XFOR Price Action: Shares of X4 Pharmaceuticals closed at $5.70 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0428">XFOR shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0428"><img loading="lazy" decoding="async" width="876" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071347/image-188.png" alt="" class="wp-image-890619" style="width:566px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071347/image-188.png 876w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071347/image-188-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28071347/image-188-768x737.png 768w" sizes="(max-width: 876px) 100vw, 876px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45007044/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend-yields-5">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Comments

Rua Gold

Rua Gold (NZAUF) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL